Table 4.
Differences in patient characteristics between patent and non-patent anastomosis groups
| Characteristics | Patent anastomosis N = 19 (76%) | Non-patent anastomosis N = 4 (16%) | OR (95% CI) |
|---|---|---|---|
| Mean age (years) | 57.7 ± 8.6 | 64.3 ± 9.8 | 0.9 (0.8–1.1) |
| Mean BMI (preop) (kg/m2) | 25.4 ± 3.7 | 26.3 ± 3.7 | 0.9 (0.7–1.3) |
| ISL classification (%) | I = 10.5 | I = 0.0 | |
| IIA = 68.4 | IIA = 50.0 | 3.3 (0.3–31.1) | |
| IIB = 21.1 | IIB = 50.0 | 0.3 (0.0–2.9) | |
| ICG stage (%) | II = 31.6 | II = 0.0 | |
| III = 57.9 | III = 25.0 | 16.5 (1.1–250.2) | |
| IV = 10.5 | IV = 75.0 | 0.1 (0.0–0.9) | |
| Mean years from lymphedema onset | 5.9 ± 4.7 | 8.3 ± 7.4 | 0.9 (0.8–1.1) |
| Infections | |||
| Preoperative (%) | 28.6 | 75.0 | 0.1 (0.0–1.5) |
| Postoperative (%) | 4.0 | 50.0 | 0.1 (0.0–1.7) |
| Mean number of anastomosis | 2.0 | 1.5 | 3.7 (0.5–27.9) |
OR odds ratio, CI confidence interval, ISL International Society of Lymphology, ICG indocyanine green